Search - tctmd.com

Displaying 21 - 40 of 112

Sort: Relevancy | Date

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

Presentation TCT 2020

TCT 385: Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA

Presenter: Christopher Rajkumar

October 14, 2020

Presentation TCT 2020

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

Presenter: Mahmoud Barbarawi

October 14, 2020

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Todd Neale

September 30, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Advertisement

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

FAVOR III China Adds Strength to Value of QFR-Guided PCI

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Good Long-term Results With FANTOM BVS, but More Data Needed

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

TCT 385: Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content